Menu
Back to User profile » Dr Jianxing Zeng
Papers published by Dr Jianxing Zeng:
Inflammation-Related Marker NrLR Predicts Prognosis in AFP-Negative HCC Patients After Curative Resection
Wu Q, Zeng J, Zeng J
Journal of Hepatocellular Carcinoma 2023, 10:193-202
Published Date: 8 February 2023
Prognostic Significance of Platelet-to-Lymphocyte Ratio (PLR) in Extrahepatic Metastasis of Hepatocellular Carcinoma After Curative Resection
Chen Y, Zeng J, Guo P, Zeng J, Liu J
Cancer Management and Research 2021, 13:1395-1405
Published Date: 12 February 2021
Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
Huang Q, Lin K, Wang L, Zeng J, Liu H, Ding Z, Zeng Y, Liu J
Cancer Management and Research 2020, 12:9183-9195
Published Date: 28 September 2020
Development and Validation of a Prognostic Nomogram to Predict the Long-Time Prognosis in Non-B, Non-C Hepatocellular Carcinoma
Lin K, Huang Q, Huo Y, Zeng J, Ding Z, Guo P, Chen Z, Zeng Y, Liu J
Cancer Management and Research 2020, 12:7771-7781
Published Date: 24 August 2020
Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study
Zeng J, Lin K, Liu H, Huang Y, Guo P, Zeng Y, Zeng J, Liu J
Cancer Management and Research 2020, 12:6597-6606
Published Date: 30 July 2020
Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma
Huang Y, Zeng J, Liu T, Lin X, Guo P, Zeng J, Zhou W, Liu J
OncoTargets and Therapy 2020, 13:4559-4567
Published Date: 22 May 2020
DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro
Huang Y, Zeng J, Liu T, Xu Q, Song X, Zeng J
Cancer Management and Research 2020, 12:3247-3255
Published Date: 8 May 2020